Ted Drogendijk

2.1k citations
22 papers · 1.6k · 1 hit paper · h-index 13

Impact in

  • Urology top 0.1%
    • Urinary Bladder and Prostate Research
    • Urological Disorders and Treatments
    • Pelvic floor disorders treatments

Papers in

    • Urinary Bladder and Prostate Research 17
    • Urinary Tract Infections Management 4

Ted Drogendijk

22 papers receiving 1.6k citations

Ted Drogendijk's Hit Papers

Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trial 2012 · 336 citations
3360+4+9Years since publication100200300

Peers

Ted Drogendijk
Comparison fields: 5 of 63
  • Urology 1.4k
  • Rheumatology 603
  • Epidemiology 444
  • Gastroenterology 43
  • Endocrinology, Diabetes and Metabolism 65
Replace Mary Beth Blauwet with:
Mary Beth Blauwet United States
Arcangelo Sebastianelli Italy
Weizhong He United States
Matteo Salvi Italy
M. C. DELAUCHE‐CAVALLIER France
K‐E. Andersson Sweden
Shyh-Chyan Chen Taiwan
Hüseyin Beşiroğlu Türkiye
Amy T. Ko United States
Ajay Pabby United States
Ted Drogendijk relative to Mary Beth Blauwet United States Mary Beth Blauwet's profile →
Citations per field
00.5×3.3×
Mary Beth Blauwet · 1×
Citations per year

Countries citing papers authored by Ted Drogendijk

Since Specialization
Citations

This map shows the geographic impact of Ted Drogendijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ted Drogendijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ted Drogendijk more than expected).

Fields of papers citing papers by Ted Drogendijk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ted Drogendijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ted Drogendijk. The network helps show where Ted Drogendijk may publish in the future.

Co-authors

The 25 scholars most cited alongside Ted Drogendijk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ted Drogendijk Line = papers co-authored together Ted Drogendijk links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trial
Hit paper breakdown →
2012336
2 2004251
3 2012248
4 2005247
5 2008111
6 2013111
7 201370
8 201450
9 201244
10 201329
11 199427
12 201326
13 199423
14 201211
15 201410
16 20037
17 20105
18 20073
19 20133
20
The efficacy of solifenacin 5/10mg on ‘urgency’ endpoints in different OAB patient populations: subanalysis of results from the randomised, double-blind SUNRISE study
20082

About Ted Drogendijk

Ted Drogendijk is a scholar working on Urology, Epidemiology, Rheumatology, Surgery and Oncology, having authored 22 papers that have together received 1.6k indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (17 papers), Urinary Tract Infections Management (4 papers), Pelvic floor disorders treatments (3 papers), Hormonal and reproductive studies (1 paper), Inflammatory mediators and NSAID effects (1 paper), Organophosphorus compounds synthesis (1 paper), Multiple Myeloma Research and Treatments (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Urology (1.4k citations), Rheumatology (603 citations), Epidemiology (444 citations), Gastroenterology (43 citations) and Endocrinology, Diabetes and Metabolism (65 citations). Ted Drogendijk has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Christopher R. Chapple, John Bolodeoku, Arwin Ridder, Peter J. Boerrigter, L. Cardozo, R. J. Millard, Nancy Martin, Igor V. Kuzmin, Caroline A. Dorrepaal and D.M. Wright. Their work appears in journals such as European Urology, British Journal of Urology, Urology, Value in Health and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact